Epinastine was safe and effective in treating adults with cedar pollen allergic conjunctivitis compared with placebo and olopatadine, according to recent Japanese study results.“Although the estimated prevalence of allergic conjunctival disease is approximately 15% to 20%, increasing numbers of patients are developing cedar pollinosis, and the disease is a major public health problem in Japan,” the researchers wrote, with ocular itching affecting patients’ quality of life.
Month: August 2014
New Treatments for Diabetic Macular Edema | Diabetic Retinopathy
Over the past 2 years, several new treatments have become FDA approved for treating diabetic retinopathy!
Allergan receives written requests for special stockholder meeting
Allergan has received stockholders’ written requests for a special stockholders’ meeting. The requests were delivered by Pershing Square Capital Management, which is attempting to complete a merger between Allergan and Valeant Pharmaceuticals. As part of the special meeting, Allergan stockholders would be asked to replace a majority of the company’s existing directors and address other matters related to Valeant’s merger proposal, according to a press release from Allergan.
DNA test shows potential for improving management of congenital cataract
Researchers found that they could enhance the diagnosis of bilateral congenital cataract by integrating genomic data from next-generation sequencing and phenotypic data.The researchers believe that this comprehensive screen will broaden access to genet…
DNA test shows potential for improving management of congenital cataract
Researchers found that they could enhance the diagnosis of bilateral congenital cataract by integrating genomic data from next-generation sequencing and phenotypic data.The researchers believe that this comprehensive screen will broaden access to genet…
CMS returns one-third of Open Payments data due to errors
In an effort to ensure accurate information is included in their Open Payments database, CMS announced it has returned approximately one-third of records submitted to manufacturers and group purchasing organizations due to intermingled and erroneous da…
PRK enhancement after LASIK safety corrects near, distance visual acuity
PRK enhancement after LASIK improved visual acuity and reduced cylinder in cases that were not suitable for flap relifting, according to study findings.The retrospective study included 43 patients who underwent photorefractive keratectomy (PRK) enhance…
DNA test for congenital cataracts leads to faster, more accurate diagnoses of rare diseases linked to childhood blindness
Researchers in the United Kingdom have demonstrated that advanced DNA testing for congenital cataracts can quickly and accurately diagnose a number of rare diseases marked by childhood blindness…
Ampio to request FDA for unmasked trial of DME treatment
Ampio Pharmaceuticals announced it plans to request that the U.S. Food and Drug Administration allow the company to unmask the OptimEyes 505(b)2 clinical trial, complete the analysis and present all of the data.The OptimEyes study included 359 patients…
Native American ancestry a risk factor for diabetic retinopathy
New research led by the University of Southern California (USC) Eye Institute, part of Keck Medicine of USC, shows for the first time that Native American ancestry is a significant risk factor for…
Top 5 videos from ASRS
The American Society of Retina Specialists meeting in San Diego included the latest clinical research on retinal diseases. Treatments for age-related macular degeneration, diabetic macular edema, and other retinal diseases continue to evolve with the i…
Best course of treatment for endophthalmitis identified
The most common cause of endophthalmitis, a potentially blinding condition that can occur after eye trauma, eye surgery, and eye injections, are the well-known staphylococci (“staph”) and…
Favorable long-term outcomes achieved with fixed-interval anti-VEGF dosing
At the American Society of Retina Specialists meeting in San Diego, Marc Peden, MD, discusses his presentation of long-term visual outcomes of patients receiving continuous, fixed-interval dosing of Lucentis.
Internet Brownout Exposes Risk of Cloud-Based EHRs
Many physicians using a highly rated EHR program could not log in because of traffic jams on the information superhighway. Medscape Medical News
Bionic eye system gains financial support in France
The French Ministry of Health has approved financial support for a bionic eye treatment, according to a Second Sight Medical Products press release.The approval of the Argus II Retinal Prosthesis System (Second Sight) comes after the March 18, 2014, de…
Declines in vision, activity linked to increased mortality risk
Researchers discovered a direct relationship between loss of visual acuity and decline in instrumental activities of daily living levels, which increases the risk of mortality in older adults.The prospective longitudinal study included 2,520 noninstitu…
Declines in vision, activity linked to increased mortality risk
Researchers discovered a direct relationship between loss of visual acuity and decline in instrumental activities of daily living levels, which increases the risk of mortality in older adults.The prospective longitudinal study included 2,520 noninstitu…
PRK with cross-linking markedly reduces keratocyte, nerve density
PRK combined with corneal collagen cross-linking had a transient effect on corneal innervation and a significant effect on keratocyte density for up to 4 years postoperatively, researchers found.The researchers prospectively analyzed 17 eyes of 17 pati…
Vision loss adversely affects daily function which can increase risk for death
Vision loss can adversely affect the ability of older adults to perform instrumental activities of daily living (IADL), such as using the telephone, shopping and doing housework, which are all…
Patient selection key in ocriplasmin for vitreomacular interface disease
At the American Society of Retina Specialists meeting in San Diego, Carl Regillo, MD, shares his early and recent experience with ocriplasmin in treating vitreomacular interface disease.